Skip to content
ONB$25.02-0.01(-0.04%)Old National Chairman and CEO Jim Ryan Named Chair-Elect of the American Bankers Association[2:07:00 PM ET]BCRD$5.530.00(0.00%)BlueOne Technologies Announces Enhance Global Remittance Platform[2:04:41 PM ET]CWK$12.14+0.23(+1.97%)Cushman & Wakefield Arranges $130 Million Sale of Seasons of Traverse Mountain in Lehi, Utah[2:01:00 PM ET]CTAS$214.69-11.24(-4.97%)Cintas Corporation Announces Quarterly Cash Dividend[2:00:00 PM ET]QNBC$46.41+0.41(+0.89%)QNB Corp. Reports Third Quarter 2026 Results[1:59:23 PM ET]CNXC$31.23-0.78(-2.44%)Concentrix Breaks the Language Barrier with Live Voice Translation[1:55:00 PM ET]CEG$258.31+5.83(+2.31%)Constellation Secures Conditional DOE Loan Commitment of up to $5 Billion to Expand Nuclear Output[1:35:00 PM ET]TXTM$0.01+0.00(+4.76%)Canouse Announces Unsatisfied Federal Judgment Against Protext Mobility, Inc. (OTC: TXTM)[1:35:00 PM ET]ARAI$0.11-0.00(-1.79%)Arrive AI Installs First Arrive Point(TM) Residential Unit[1:23:00 PM ET]

WGS · NASDAQ

GeneDx Holdings Corp.

$63.43 +2.30 (+3.76%)

Company overview

GeneDx Holdings Corp. is a patient-centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and define optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, Connecticut.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$1.9B
Employees
1,000
Headquarters
Stamford, CT
Website
genedx.com
CEO
Katherine A. Stueland
Listed
November 4, 2020
P/E
-23.80
Dividend yield
0.00%

Company financials

Revenue
$443M
Gross profit
$303M
Operating income
-$34.2M
EBITDA
-$48.5M
Net income
-$77.8M
EPS
-$2.66
Total assets
$506M
Total debt
$168M
Gross margin
68.35%
Net margin
-17.58%
Earnings yield
-4.20%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

29.2948.9968.7088.40108.10
WGS 1D NASDAQ O58.07H63.44L58.00C61.26+5.11 (+9.10%)Vol1.00M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
WGSGeneDx Holdings Corp. Legal Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Investors to Reach Out ACCESS Newswire
WGSGeneDx Holdings Corp. Press release GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026 Business Wire
WGSGeneDx Holdings Corp. Legal Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect ACCESS Newswire
WGSGeneDx Holdings Corp. Stock news GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026 Business Wire
WGSGeneDx Holdings Corp. Stock news GeneDx (NASDAQ:WGS) Stock Falls 5.5% – Here’s What Happened Defense World
WGSGeneDx Holdings Corp. Stock news Analyzing GeneDx (NASDAQ:WGS) and LifeMD (NASDAQ:LFMD) Defense World
WGSGeneDx Holdings Corp. Stock news Comparing GeneDx (NASDAQ:WGS) & Brookdale Senior Living (NYSE:BKD) Defense World
WGSGeneDx Holdings Corp. Stock news GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026 GuruFocus
WGSGeneDx Holdings Corp. Stock news GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026 Business Wire
WGSGeneDx Holdings Corp. Stock news GeneDx Holdings Corp (WGS) Shares Surge 4.3% -- What GF Score of 67 Tells Investors GuruFocus
WGSGeneDx Holdings Corp. Stock news GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care Business Wire
WGSGeneDx Holdings Corp. Stock news Kevin Feeley Sells 3,728 Shares of GeneDx (NASDAQ:WGS) Stock Defense World
WGSGeneDx Holdings Corp. Press release GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C Business Wire
WGSGeneDx Holdings Corp. Stock news 3 Promising Genomics Stocks in the Spotlight in 2026 Zacks Investment Research
WGSGeneDx Holdings Corp. Press release GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree Business Wire
WGSGeneDx Holdings Corp. Stock news GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors GuruFocus
WGSGeneDx Holdings Corp. Press release GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's Business Wire
WGSGeneDx Holdings Corp. Stock news Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? Zacks Investment Research
WGSGeneDx Holdings Corp. Stock news GeneDx: Why I Think The Worst Is Behind The Business Seeking Alpha
WGSGeneDx Holdings Corp. Stock news Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Value Says Overvalued GuruFocus
FAQ

Questions about GeneDx Holdings Corp.

What does GeneDx Holdings Corp. do?
GeneDx Holdings Corp. is a patient-centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and define optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, Connecticut.
What is WGS's market cap?
GeneDx Holdings Corp. (WGS) is a listed stock with a live quote. The latest market cap on this page is $1.9B.
Where is GeneDx Holdings Corp. headquartered?
GeneDx Holdings Corp. is headquartered in Stamford, CT.
How do I get WGS news from the API?
Call GET /v1/news?tickers=WGS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does WGS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for WGS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the WGS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.